IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Bafna Pharmaceuticals IPO listing price is ₹ 38.50, issue price is ₹ 40.00, and currently trading at [●] as on [●]. Bafna Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Bafna Pharmaceuticals IPO is a Fixed Price listing on BSE,NSE exchange. The company is based in Chennai and caters to Pharmaceutical sector. Keynote Financial Services , Ashika Capital are the merchant bankers of Bafna Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 27th December 2007.
Bafna Pharmaceuticals IPO offer price is ₹ 40.00 and got listed at ₹ 38.50. Read Bafna Pharmaceuticals IPO details mentioned above.The IPO of Bafna Pharmaceuticals Limited was listed on 27th June 2008. As of today, Bafna Pharmaceuticals IPO is trading at [●], compared to the previous day’s close of [●]. Read the report above for detailed IPO performance.
The issue price of Bafna Pharmaceuticals IPO was ₹ 40.00 per equity share.
Bafna Pharmaceuticals IPO was listed at ₹38.50 on the stock exchange on 27th June 2008. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of [●], the current market price of Bafna Pharmaceuticals IPO is [●].
The 52-week high for Bafna Pharmaceuticals IPO is ₹ 178.55, while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Bafna Pharmaceuticals IPO listed at ₹ 38.50 against the issue price of ₹ 40.00 per equity share, showing a listing day gain/loss of -1.5 (-3.75%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Bafna Pharmaceuticals IPO stock moved from its listing price of ₹ 38.50 to the current price of ₹[●] per equity share, reflecting a change of -100.00% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Bafna Pharmaceuticals IPO issue date of 27th June 2008 and CMP of ₹[●], the estimated CAGR is approximately -100%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 40.00
Listing Price :
₹ 38.50
Previous Day Closing
[●]
Bafna Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Bafna Pharmaceuticals Financial Review Page
Merchant Banker(s) of Bafna Pharmaceuticals IPO: Keynote Financial Services Limited , Ashika Capital Limited
Bafna Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Bafna Pharmaceuticals IPO listed at a listing price of 38.50 against the offer price of 40.00.
The current market price of Bafna Pharmaceuticals is .
Why Us?
